• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IMM 5.22% 31.8¢

IMMUTEP LIMITED - Announcements

Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company... Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing Lymphocyte Activation Gene (LAG)-3 immunotherapies for cancer and autoimmune diseases. Its lead product candidate, Eftilagimod alpha (efti or IMP321), is a soluble LAG-3Ig fusion protein that is an antigen-presenting cell (APC) agonist designed to capitalize on LAG-3’s ability to drive the adaptive and innate immune systems against cancer. IMP761 is an immunosuppressive agonist antibody to LAG-3, which has the potential to address the root cause of autoimmune diseases by specifically silencing autoimmune memory T cells. Its third product candidate is LAG525, an antagonist (blocking) antibody targeting the LAG-3 molecule on T cells with potential applications in the treatment of cancer. Its fourth product candidate is IMP731 (GSK 781), a depleting (cytotoxic) antibody that is intended to destroy LAG-3 expressing activated T cells involved in autoimmunity.More

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk

IMM Appendix 3G02/10/20 download Created with Sketch. 262.09KB
IMM Annual Report filed on Form 20-F with SEC28/09/20 download Created with Sketch. 758.16KB
IMM Notice of Annual General Meeting/Proxy Form25/09/20 download Created with Sketch. 1.12MB
IMM Appendix 4G & Corporate Governance Statement25/09/20 download Created with Sketch. 419.74KB
IMM Annual Report to shareholders25/09/20 download Created with Sketch. 1.74MB
IMM Immutep reports improving results from INSIGHT-004 trialPRICE SENSITIVE18/09/20 download Created with Sketch. 269.41KB
IMM Improving results from stage 1 of TACTI-002 ph II trialPRICE SENSITIVE18/09/20 download Created with Sketch. 281.8KB
IMM Change in substantial holding14/09/20 download Created with Sketch. 1.12MB
IMM 2020 AGM & Key Dates11/09/20 download Created with Sketch. 254.28KB
IMM IMM & Monash Uni receive funding grant for LAG-3 ResearchPRICE SENSITIVE31/08/20 download Created with Sketch. 264.06KB
IMM New data to be presented at ESMO for eftilagimod alpha26/08/20 download Created with Sketch. 307.71KB
IMM Appendix 4E & 2020 Full Year Statutory AccountsPRICE SENSITIVE25/08/20 download Created with Sketch. 1.19MB
IMM Recruitment of stage 1 of part B in TACTI-002 study completePRICE SENSITIVE18/08/20 download Created with Sketch. 243.59KB
IMM Immutep Investor Update17/08/20 download Created with Sketch. 1.44MB
IMM Immutep granted US patent for eftilagimod alphaPRICE SENSITIVE11/08/20 download Created with Sketch. 206.23KB
IMM Lapse of Unlisted Options11/08/20 download Created with Sketch. 231.32KB
IMM Change in substantial holding27/07/20 download Created with Sketch. 1.89MB
IMM Immutep Quarterly Activities Report & Appendix 4CPRICE SENSITIVE23/07/20 download Created with Sketch. 508.74KB
IMM Change in substantial holding21/07/20 download Created with Sketch. 1.9MB
IMM US patent granted for IMP701 antibodyPRICE SENSITIVE15/07/20 download Created with Sketch. 134.22KB
IMM Immutep Completes Recruitment for Part A of TACTI-002 trialPRICE SENSITIVE29/06/20 download Created with Sketch. 239.04KB
IMM Immutep receives A$1,437,826 R&D Tax IncentivePRICE SENSITIVE22/06/20 download Created with Sketch. 228.17KB
IMM Immutep announces improving data from TACTI-002 ph II trialPRICE SENSITIVE01/06/20 download Created with Sketch. 301.55KB
IMM Immutep Reports First Results from INSIGHT-004 StudyPRICE SENSITIVE01/06/20 download Created with Sketch. 270.11KB
IMM Immutep receives $3.6M R&D French tax incentivePRICE SENSITIVE29/05/20 download Created with Sketch. 252.82KB
IMM Immutep webcast to present new data from 2020 ASCO meeting27/05/20 download Created with Sketch. 266.15KB
IMM Becoming a substantial holder from AEF07/05/20 download Created with Sketch. 228.27KB
IMM Immutep granted Japanese patent for eftilagimod alphaPRICE SENSITIVE07/05/20 download Created with Sketch. 202.35KB
IMM Change in substantial holding07/05/20 download Created with Sketch. 177.48KB
IMM Cleansing Notice05/05/20 download Created with Sketch. 190.72KB
IMM Appendix 2A04/05/20 download Created with Sketch. 280.16KB
IMM Immutep presents at NWR Virtual Small Cap Health Conference01/05/20 download Created with Sketch. 239.47KB
IMM INSIGHT-004 and TACTI-002 data to be presented at ASCOPRICE SENSITIVE30/04/20 download Created with Sketch. 326.15KB
IMM Proposed issue of Securities - IMMPRICE SENSITIVE29/04/20 download Created with Sketch. 29.45KB
IMM Proposed issue of Securities - IMM29/04/20 download Created with Sketch. 25.51KB
IMM Immutep Investor PresentationPRICE SENSITIVE29/04/20 download Created with Sketch. 2.12MB
IMM Immutep completes A$12 million placementPRICE SENSITIVE29/04/20 download Created with Sketch. 302.81KB
IMM Immutep Reports Positive Phase II TACTI-002 DataPRICE SENSITIVE28/04/20 download Created with Sketch. 387.29KB
IMM Trading HaltPRICE SENSITIVE27/04/20 download Created with Sketch. 265.26KB
IMM Enrollment completed for the INSIGHT-004 StudyPRICE SENSITIVE22/04/20 download Created with Sketch. 237.88KB
IMM Immutep March Quarterly Activities Report & Appendix 4CPRICE SENSITIVE20/04/20 download Created with Sketch. 433.73KB
IMM Immutep advances its LAG-3 agonist for autoimmune diseasesPRICE SENSITIVE16/04/20 download Created with Sketch. 299.3KB
IMM Immutep presents TACTI-002 data at AACR Virtual MeetingPRICE SENSITIVE14/04/20 download Created with Sketch. 246.66KB
IMM EOC Pharma confirms plans to advance Efti in China for MBCPRICE SENSITIVE08/04/20 download Created with Sketch. 255.3KB
IMM Immutep AIPAC Ph2b Clinical Results & Update Webcast SlidesPRICE SENSITIVE26/03/20 download Created with Sketch. 979.72KB
IMM Immutep reports supportive efficacy data from AIPAC studyPRICE SENSITIVE25/03/20 download Created with Sketch. 283.61KB
IMM Immutep's Partner, EOC completes recruitment of Phase 120/03/20 download Created with Sketch. 265.76KB
IMM Change of Director's Interest Notice - Mr Chamberlain16/03/20 download Created with Sketch. 195.38KB
IMM Immutep receives 2nd IND approval for efti from US FDAPRICE SENSITIVE09/03/20 download Created with Sketch. 255.32KB
IMM Change in substantial holding02/03/20 download Created with Sketch. 248.97KB
IMM Immutep Clinical Update & Results Global Webcast Slides25/02/20 download Created with Sketch. 1.08MB
IMM Change in substantial holding21/02/20 download Created with Sketch. 245.3KB
IMM Half Yearly Report and AccountsPRICE SENSITIVE21/02/20 download Created with Sketch. 779.6KB
IMM Immutep reports positive TACTI-002 dataPRICE SENSITIVE19/02/20 download Created with Sketch. 372.43KB
IMM Change in substantial holding05/02/20 download Created with Sketch. 230.49KB
IMM Immutep to present TACTI-002 data at German Cancer Congress04/02/20 download Created with Sketch. 271.82KB
IMM Immutep Activities ReportPRICE SENSITIVE29/01/20 download Created with Sketch. 243.88KB
IMM Appendix 4C - quarterlyPRICE SENSITIVE29/01/20 download Created with Sketch. 185.6KB
IMM Immutep Corporate Presentation10/01/20 download Created with Sketch. 1.44MB
IMM Immutep expands Part C of TACTI-002 due to positive dataPRICE SENSITIVE09/01/20 download Created with Sketch. 255.17KB
IMM Change in substantial holding06/01/20 download Created with Sketch. 258.08KB
IMM Change of Director's Interest Notice02/01/20 download Created with Sketch. 191.84KB
IMM Appendix 3B02/01/20 download Created with Sketch. 501.39KB
IMM INSIGHT-004 clinical trial updatePRICE SENSITIVE19/12/19 download Created with Sketch. 268.57KB
IMM Change of Director's Interest Notice - Mr Meyers09/12/19 download Created with Sketch. 195.96KB
IMM Change of Director's Interest Notice - Dr Howard09/12/19 download Created with Sketch. 186.22KB
IMM Change of Director's Interest Notice - Mr Voigt09/12/19 download Created with Sketch. 187.15KB
IMM Appendix 3B02/12/19 download Created with Sketch. 552.38KB
IMM Immutep Investor Update22/11/19 download Created with Sketch. 2.5MB
IMM Immutep announces European patent grant for LAG525 antibodyPRICE SENSITIVE14/11/19 download Created with Sketch. 222.42KB
IMM IMM presents positive interim phase 2 TACTI-002 data at SITCPRICE SENSITIVE08/11/19 download Created with Sketch. 313.67KB
IMM Update - Consolidation/Split - IMM01/11/19 download Created with Sketch. 34.84KB
IMM Results of Annual General Meeting01/11/19 download Created with Sketch. 209.7KB
IMM 2019 AGM CEO Presentation01/11/19 download Created with Sketch. 1.03MB
IMM 2019 AGM Chairman's Address01/11/19 download Created with Sketch. 212.2KB
IMM Consolidation/Split - IMM31/10/19 download Created with Sketch. 34.73KB
IMM Operational UpdatePRICE SENSITIVE28/10/19 download Created with Sketch. 304.46KB
IMM Change in substantial holding24/10/19 download Created with Sketch. 266.95KB
IMM Appendix 4C - quarterlyPRICE SENSITIVE23/10/19 download Created with Sketch. 164.66KB
IMM Immutep presents positive TACTI-mel melanoma trial dataPRICE SENSITIVE15/10/19 download Created with Sketch. 2.5MB
IMM Immutep receives A$2.5M R&D French Tax IncentivePRICE SENSITIVE10/10/19 download Created with Sketch. 257.96KB
IMM Immutep to present data at upcoming Industry Conferences10/10/19 download Created with Sketch. 231.99KB
IMM Change of Director's Interest Notice - Mr Chamberlain04/10/19 download Created with Sketch. 197.37KB
IMM Change of Director's Interest Notice - Mr Meyers04/10/19 download Created with Sketch. 195.79KB
IMM Appendix 3B03/10/19 download Created with Sketch. 468.71KB
IMM Immutep Investor Presentation30/09/19 download Created with Sketch. 2.16MB
IMM Notice of Annual General Meeting/Proxy Form30/09/19 download Created with Sketch. 904.71KB
IMM Appendix 4G & Corporate Governance Statement30/09/19 download Created with Sketch. 376.93KB
IMM Annual Report to shareholders30/09/19 download Created with Sketch. 1.11MB
IMM Immutep expands Part A of TACTI-002 due to positive dataPRICE SENSITIVE26/09/19 download Created with Sketch. 266KB
IMM Annual Report filed on Form 20-F with SEC24/09/19 download Created with Sketch. 961.08KB
IMM Immutep to receive GBP4M Milestone Payment from GSKPRICE SENSITIVE23/09/19 download Created with Sketch. 231.92KB
IMM Japanese patent granted for LAG525 antibodyPRICE SENSITIVE17/09/19 download Created with Sketch. 224.71KB
IMM Immutep granted European patent for IMP321 in cancerPRICE SENSITIVE22/08/19 download Created with Sketch. 222.26KB
IMM Appendix 4E & 2019 Full Year Statutory AccountsPRICE SENSITIVE20/08/19 download Created with Sketch. 1.22MB
IMM Ceasing to be a substantial holder from AEF13/08/19 download Created with Sketch. 155.46KB
IMM Change in substantial holding09/08/19 download Created with Sketch. 189.91KB
IMM Change of Director's Interest Notice - Mr Chamberlain07/08/19 download Created with Sketch. 195.07KB
IMM Change of Director's Interest Notice - Mr Voigt07/08/19 download Created with Sketch. 190.83KB
IMM Immutep completes fully underwritten A$6M Entitlement Offer06/08/19 download Created with Sketch. 275.64KB
IMM Appendix 3G
02/10/20 download Created with Sketch. 262.09KB
IMM Annual Report filed on Form 20-F with SEC
28/09/20 download Created with Sketch. 758.16KB
IMM Notice of Annual General Meeting/Proxy Form
25/09/20 download Created with Sketch. 1.12MB
IMM Appendix 4G & Corporate Governance Statement
25/09/20 download Created with Sketch. 419.74KB
IMM Annual Report to shareholders
25/09/20 download Created with Sketch. 1.74MB
IMM Immutep reports improving results from INSIGHT-004 trial
18/09/20PRICE SENSITIVE download Created with Sketch. 269.41KB
IMM Improving results from stage 1 of TACTI-002 ph II trial
18/09/20PRICE SENSITIVE download Created with Sketch. 281.8KB
IMM Change in substantial holding
14/09/20 download Created with Sketch. 1.12MB
IMM 2020 AGM & Key Dates
11/09/20 download Created with Sketch. 254.28KB
IMM IMM & Monash Uni receive funding grant for LAG-3 Research
31/08/20PRICE SENSITIVE download Created with Sketch. 264.06KB
IMM New data to be presented at ESMO for eftilagimod alpha
26/08/20 download Created with Sketch. 307.71KB
IMM Appendix 4E & 2020 Full Year Statutory Accounts
25/08/20PRICE SENSITIVE download Created with Sketch. 1.19MB
IMM Recruitment of stage 1 of part B in TACTI-002 study complete
18/08/20PRICE SENSITIVE download Created with Sketch. 243.59KB
IMM Immutep Investor Update
17/08/20 download Created with Sketch. 1.44MB
IMM Immutep granted US patent for eftilagimod alpha
11/08/20PRICE SENSITIVE download Created with Sketch. 206.23KB
IMM Lapse of Unlisted Options
11/08/20 download Created with Sketch. 231.32KB
IMM Change in substantial holding
27/07/20 download Created with Sketch. 1.89MB
IMM Immutep Quarterly Activities Report & Appendix 4C
23/07/20PRICE SENSITIVE download Created with Sketch. 508.74KB
IMM Change in substantial holding
21/07/20 download Created with Sketch. 1.9MB
IMM US patent granted for IMP701 antibody
15/07/20PRICE SENSITIVE download Created with Sketch. 134.22KB
IMM Immutep Completes Recruitment for Part A of TACTI-002 trial
29/06/20PRICE SENSITIVE download Created with Sketch. 239.04KB
IMM Immutep receives A$1,437,826 R&D Tax Incentive
22/06/20PRICE SENSITIVE download Created with Sketch. 228.17KB
IMM Immutep announces improving data from TACTI-002 ph II trial
01/06/20PRICE SENSITIVE download Created with Sketch. 301.55KB
IMM Immutep Reports First Results from INSIGHT-004 Study
01/06/20PRICE SENSITIVE download Created with Sketch. 270.11KB
IMM Immutep receives $3.6M R&D French tax incentive
29/05/20PRICE SENSITIVE download Created with Sketch. 252.82KB
IMM Immutep webcast to present new data from 2020 ASCO meeting
27/05/20 download Created with Sketch. 266.15KB
IMM Becoming a substantial holder from AEF
07/05/20 download Created with Sketch. 228.27KB
IMM Immutep granted Japanese patent for eftilagimod alpha
07/05/20PRICE SENSITIVE download Created with Sketch. 202.35KB
IMM Change in substantial holding
07/05/20 download Created with Sketch. 177.48KB
IMM Cleansing Notice
05/05/20 download Created with Sketch. 190.72KB
IMM Appendix 2A
04/05/20 download Created with Sketch. 280.16KB
IMM Immutep presents at NWR Virtual Small Cap Health Conference
01/05/20 download Created with Sketch. 239.47KB
IMM INSIGHT-004 and TACTI-002 data to be presented at ASCO
30/04/20PRICE SENSITIVE download Created with Sketch. 326.15KB
IMM Proposed issue of Securities - IMM
29/04/20PRICE SENSITIVE download Created with Sketch. 29.45KB
IMM Proposed issue of Securities - IMM
29/04/20 download Created with Sketch. 25.51KB
IMM Immutep Investor Presentation
29/04/20PRICE SENSITIVE download Created with Sketch. 2.12MB
IMM Immutep completes A$12 million placement
29/04/20PRICE SENSITIVE download Created with Sketch. 302.81KB
IMM Immutep Reports Positive Phase II TACTI-002 Data
28/04/20PRICE SENSITIVE download Created with Sketch. 387.29KB
IMM Trading Halt
27/04/20PRICE SENSITIVE download Created with Sketch. 265.26KB
IMM Enrollment completed for the INSIGHT-004 Study
22/04/20PRICE SENSITIVE download Created with Sketch. 237.88KB
IMM Immutep March Quarterly Activities Report & Appendix 4C
20/04/20PRICE SENSITIVE download Created with Sketch. 433.73KB
IMM Immutep advances its LAG-3 agonist for autoimmune diseases
16/04/20PRICE SENSITIVE download Created with Sketch. 299.3KB
IMM Immutep presents TACTI-002 data at AACR Virtual Meeting
14/04/20PRICE SENSITIVE download Created with Sketch. 246.66KB
IMM EOC Pharma confirms plans to advance Efti in China for MBC
08/04/20PRICE SENSITIVE download Created with Sketch. 255.3KB
IMM Immutep AIPAC Ph2b Clinical Results & Update Webcast Slides
26/03/20PRICE SENSITIVE download Created with Sketch. 979.72KB
IMM Immutep reports supportive efficacy data from AIPAC study
25/03/20PRICE SENSITIVE download Created with Sketch. 283.61KB
IMM Immutep's Partner, EOC completes recruitment of Phase 1
20/03/20 download Created with Sketch. 265.76KB
IMM Change of Director's Interest Notice - Mr Chamberlain
16/03/20 download Created with Sketch. 195.38KB
IMM Immutep receives 2nd IND approval for efti from US FDA
09/03/20PRICE SENSITIVE download Created with Sketch. 255.32KB
IMM Change in substantial holding
02/03/20 download Created with Sketch. 248.97KB
IMM Immutep Clinical Update & Results Global Webcast Slides
25/02/20 download Created with Sketch. 1.08MB
IMM Change in substantial holding
21/02/20 download Created with Sketch. 245.3KB
IMM Half Yearly Report and Accounts
21/02/20PRICE SENSITIVE download Created with Sketch. 779.6KB
IMM Immutep reports positive TACTI-002 data
19/02/20PRICE SENSITIVE download Created with Sketch. 372.43KB
IMM Change in substantial holding
05/02/20 download Created with Sketch. 230.49KB
IMM Immutep to present TACTI-002 data at German Cancer Congress
04/02/20 download Created with Sketch. 271.82KB
IMM Immutep Activities Report
29/01/20PRICE SENSITIVE download Created with Sketch. 243.88KB
IMM Appendix 4C - quarterly
29/01/20PRICE SENSITIVE download Created with Sketch. 185.6KB
IMM Immutep Corporate Presentation
10/01/20 download Created with Sketch. 1.44MB
IMM Immutep expands Part C of TACTI-002 due to positive data
09/01/20PRICE SENSITIVE download Created with Sketch. 255.17KB
IMM Change in substantial holding
06/01/20 download Created with Sketch. 258.08KB
IMM Change of Director's Interest Notice
02/01/20 download Created with Sketch. 191.84KB
IMM Appendix 3B
02/01/20 download Created with Sketch. 501.39KB
IMM INSIGHT-004 clinical trial update
19/12/19PRICE SENSITIVE download Created with Sketch. 268.57KB
IMM Change of Director's Interest Notice - Mr Meyers
09/12/19 download Created with Sketch. 195.96KB
IMM Change of Director's Interest Notice - Dr Howard
09/12/19 download Created with Sketch. 186.22KB
IMM Change of Director's Interest Notice - Mr Voigt
09/12/19 download Created with Sketch. 187.15KB
IMM Appendix 3B
02/12/19 download Created with Sketch. 552.38KB
IMM Immutep Investor Update
22/11/19 download Created with Sketch. 2.5MB
IMM Immutep announces European patent grant for LAG525 antibody
14/11/19PRICE SENSITIVE download Created with Sketch. 222.42KB
IMM IMM presents positive interim phase 2 TACTI-002 data at SITC
08/11/19PRICE SENSITIVE download Created with Sketch. 313.67KB
IMM Update - Consolidation/Split - IMM
01/11/19 download Created with Sketch. 34.84KB
IMM Results of Annual General Meeting
01/11/19 download Created with Sketch. 209.7KB
IMM 2019 AGM CEO Presentation
01/11/19 download Created with Sketch. 1.03MB
IMM 2019 AGM Chairman's Address
01/11/19 download Created with Sketch. 212.2KB
IMM Consolidation/Split - IMM
31/10/19 download Created with Sketch. 34.73KB
IMM Operational Update
28/10/19PRICE SENSITIVE download Created with Sketch. 304.46KB
IMM Change in substantial holding
24/10/19 download Created with Sketch. 266.95KB
IMM Appendix 4C - quarterly
23/10/19PRICE SENSITIVE download Created with Sketch. 164.66KB
IMM Immutep presents positive TACTI-mel melanoma trial data
15/10/19PRICE SENSITIVE download Created with Sketch. 2.5MB
IMM Immutep receives A$2.5M R&D French Tax Incentive
10/10/19PRICE SENSITIVE download Created with Sketch. 257.96KB
IMM Immutep to present data at upcoming Industry Conferences
10/10/19 download Created with Sketch. 231.99KB
IMM Change of Director's Interest Notice - Mr Chamberlain
04/10/19 download Created with Sketch. 197.37KB
IMM Change of Director's Interest Notice - Mr Meyers
04/10/19 download Created with Sketch. 195.79KB
IMM Appendix 3B
03/10/19 download Created with Sketch. 468.71KB
IMM Immutep Investor Presentation
30/09/19 download Created with Sketch. 2.16MB
IMM Notice of Annual General Meeting/Proxy Form
30/09/19 download Created with Sketch. 904.71KB
IMM Appendix 4G & Corporate Governance Statement
30/09/19 download Created with Sketch. 376.93KB
IMM Annual Report to shareholders
30/09/19 download Created with Sketch. 1.11MB
IMM Immutep expands Part A of TACTI-002 due to positive data
26/09/19PRICE SENSITIVE download Created with Sketch. 266KB
IMM Annual Report filed on Form 20-F with SEC
24/09/19 download Created with Sketch. 961.08KB
IMM Immutep to receive GBP4M Milestone Payment from GSK
23/09/19PRICE SENSITIVE download Created with Sketch. 231.92KB
IMM Japanese patent granted for LAG525 antibody
17/09/19PRICE SENSITIVE download Created with Sketch. 224.71KB
IMM Immutep granted European patent for IMP321 in cancer
22/08/19PRICE SENSITIVE download Created with Sketch. 222.26KB
IMM Appendix 4E & 2019 Full Year Statutory Accounts
20/08/19PRICE SENSITIVE download Created with Sketch. 1.22MB
IMM Ceasing to be a substantial holder from AEF
13/08/19 download Created with Sketch. 155.46KB
IMM Change in substantial holding
09/08/19 download Created with Sketch. 189.91KB
IMM Change of Director's Interest Notice - Mr Chamberlain
07/08/19 download Created with Sketch. 195.07KB
IMM Change of Director's Interest Notice - Mr Voigt
07/08/19 download Created with Sketch. 190.83KB
IMM Immutep completes fully underwritten A$6M Entitlement Offer
06/08/19 download Created with Sketch. 275.64KB
(20min delay)
Last
31.8¢
Change
-0.018(5.22%)
Mkt cap ! $472.0M
Open High Low Value Volume
32.0¢ 32.8¢ 31.5¢ $502.7K 1.564M

Buyers (Bids)

No. Vol. Price($)
25 206338 31.5¢
 

Sellers (Offers)

Price($) Vol. No.
32.0¢ 96156 15
View Market Depth
Last trade - 11.45am 02/10/2024 (20 minute delay) ?
Last
32.0¢
  Change
-0.018 ( 3.12 %)
Open High Low Volume
32.5¢ 32.8¢ 31.5¢ 830552
Last updated 12.04pm 02/10/2024 ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.